Blood Vessel News and Research RSS Feed - Blood Vessel News and Research

Blood Vessels are tubes through which the blood circulates in the body. Blood vessels include a network of arteries, arterioles, capillaries, venules, and veins.
Henry Ford physicians use AngioVac device to remove tumor in kidney cancer patient

Henry Ford physicians use AngioVac device to remove tumor in kidney cancer patient

Physicians at Henry Ford Hospital successfully suctioned a cancerous tumor from a major vein in a patient with metastatic kidney cancer, clearing the way for him to undergo a minimally-invasive kidney removal. [More]
Endovascular treatment can improve patient outcomes after acute ischemic stroke

Endovascular treatment can improve patient outcomes after acute ischemic stroke

Canadian researchers have completed an international randomized controlled trial showing that a clot retrieval procedure, known as endovascular treatment (ET), can dramatically improve patient outcomes after an acute ischemic stroke. The study, led by researchers at the University of Calgary's Hotchkiss Brain Institute (HBI), shows a dramatic improvement in outcomes and a reduction in deaths from stroke. [More]
Landmark study heralds new era in stroke treatment worldwide

Landmark study heralds new era in stroke treatment worldwide

A landmark study published in the New England Journal of Medicine today heralds a new era in stroke treatment across the globe. [More]
Studies show neurointerventional surgery reduces stroke mortality rate by 50%

Studies show neurointerventional surgery reduces stroke mortality rate by 50%

Two new clinical trials on the treatment of stroke (ESCAPE and EXTEND IA) demonstrate that neurointerventional surgery significantly increases the number of patients who are able to live independently without major neurological disabilities. [More]
Retigabine drug could reduce debilitating impact of strokes

Retigabine drug could reduce debilitating impact of strokes

New research suggests that an already-approved drug could dramatically reduce the debilitating impact of strokes, which affect nearly a million Americans every year. [More]
Researchers develop tri-layered artificial blood vessels

Researchers develop tri-layered artificial blood vessels

By combining micro-imprinting and electro-spinning techniques, researchers at Shanghai University's Rapid Manufacturing Engineering Center have developed a vascular graft composed of three layers for the first time. [More]
Mathematical models of cancer behavior offer new insights on tumor growth

Mathematical models of cancer behavior offer new insights on tumor growth

Hassan Fathallah-Shaykh, M.D., Ph.D., believes that math can transform medicine, and he has the numbers to prove it. [More]
Scientists discover hidden mechanism which could explain why some cancer therapies fail trials

Scientists discover hidden mechanism which could explain why some cancer therapies fail trials

Scientists based at the University of Helsinki, Finland, have discovered a 'hidden' mechanism which could explain why some cancer therapies which aim to block tumour blood vessel growth are failing cancer trials. [More]
AP39 compound could help lower heart rate, blood pressure, and blood vessel stiffness

AP39 compound could help lower heart rate, blood pressure, and blood vessel stiffness

A gas that gives rotten eggs their distinctive odour could one day form the basis of new cardiovascular therapies. [More]
Rice researchers develop new version of hydrogel to promote wound healing

Rice researchers develop new version of hydrogel to promote wound healing

Rice University scientists have found the balance necessary to aid healing with high-tech hydrogel. [More]
UB researchers design nanoparticle that may open door for new 'hypermodal' imaging systems

UB researchers design nanoparticle that may open door for new 'hypermodal' imaging systems

Using two biocompatible parts, University at Buffalo researchers and their colleagues have designed a nanoparticle that can be detected by six medical imaging techniques. [More]
Researchers identify ten new antibodies that can possibly prevent cancer tumours

Researchers identify ten new antibodies that can possibly prevent cancer tumours

Out of a library with billions of artificial antibodies, researchers have identified ten that can possibly prevent cancer tumours from growing. [More]
New article discusses role of cytokines in breast cancer development, progression

New article discusses role of cytokines in breast cancer development, progression

Emerging data on the role of inflammation and the immune system in the development, growth, and spread of breast tumors have focused increased attention on the role cytokines such as interleukin and transforming growth factor-β play in breast cancer initiation, protection, and metastasis. [More]
Using HIV drugs to treat AMD: an interview with Dr Mark Young

Using HIV drugs to treat AMD: an interview with Dr Mark Young

NRTIs are compounds which were originally developed in the 1960s as anti-cancer agents. They are similar in structure to the bases which make up DNA, and it was hoped that they would interfere with DNA replication in fast-growing cancer cells, slowing down or stopping tumour growth. [More]
Top cancer research and clinical developments at Dana-Farber Cancer Institute in 2014

Top cancer research and clinical developments at Dana-Farber Cancer Institute in 2014

Immunotherapy, genomic profiling, and investigating game-changing drug therapies topped the list of most important cancer research and clinical developments at Dana-Farber Cancer Institute in 2014. [More]
EMA validates Synageva's sebelipase alfa MAA for LAL Deficiency

EMA validates Synageva's sebelipase alfa MAA for LAL Deficiency

Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare disorders, today announced validation by the European Medicines Agency of the Marketing Authorization Application for sebelipase alfa for LAL Deficiency. [More]
Lilly receives FDA approval for CYRAMZA (ramucirumab)

Lilly receives FDA approval for CYRAMZA (ramucirumab)

Eli Lilly and Company has received its third U.S. Food and Drug Administration approval for CYRAMZA (ramucirumab). [More]
Two-drug combination before surgery benefits women with triple-negative breast cancer

Two-drug combination before surgery benefits women with triple-negative breast cancer

A breast cancer specialist and clinical researcher at Women & Infants Hospital of Rhode Island presented research yesterday at the 2014 San Antonio Breast Cancer Symposium showing that adding either the chemotherapy drug carboplatin or the blood vessel-targeting drug bevacizumab to the standard treatment of chemotherapy before surgery helped women who have the basal-like subtype of triple-negative breast cancer. [More]
Cold 'sensor' hold key to new therapeutic target for treatment of frostbite and hypothermia

Cold 'sensor' hold key to new therapeutic target for treatment of frostbite and hypothermia

A cold 'sensor' which triggers the skin's vascular response to the cold could represent an exciting new therapeutic target for the treatment of frostbite and hypothermia, according to scientists at King's College London. [More]
Researchers pinpoint rare gene mutations that increase risk of heart attack early in life

Researchers pinpoint rare gene mutations that increase risk of heart attack early in life

A team of investigators from the Broad Institute, Massachusetts General Hospital and other leading biomedical research institutions has pinpointed rare mutations in a gene called APOA5 that increase a person's risk of having a heart attack early in life. These mutations disable the APOA5 gene and also raise the levels in the blood of triglyceride-rich lipoproteins, a type of fat. [More]
Advertisement
Advertisement